Literature DB >> 32538281

Simultaneous nicotine and oral contraceptive exposure alters brain energy metabolism and exacerbates ischemic stroke injury in female rats.

Francisca Diaz1, Ami P Raval1,2.   

Abstract

Smoking-derived nicotine (N) and oral contraceptives (OC) synergistically exacerbate ischemic brain damage in the females and underlying mechanisms remain elusive. Our published study showed that N toxicity is exacerbated by OC via altered mitochondrial function owing to a defect in the activity of cytochrome c oxidase. Here, we investigated the global metabolomic profile of brains of adolescent female Sprague-Dawley rats exposed to N ± OC. Rats were randomly exposed to saline or N + /-OC for 16-21 days followed by random allocation into two cohorts. One cohort underwent transient middle cerebral artery occlusion and histopathology was performed 30 days later. From the second cohort, cortical tissues were collected for an unbiased global metabolomic profile. Pathway enrichment analysis showed significant decrease in glucose, glucose 6-phosphate and fructose-6-phosphate, along with a significant increase in pyruvate in the N + /-OC exposed groups when compared to saline (p < 0.05), suggesting alterations in the glycolytic pathway which were confirmed by Western blot analyses of glycolytic enzymes. Infarct volume quantification showed a significant increase following N alone or N + OC as compared to saline control. Because glucose metabolism is critical for brain physiology, altered glycolysis deteriorates neural function, thus exacerbating ischemic brain damage.

Entities:  

Keywords:  Glycolysis; TCA cycle; hexokinase; metabolomics; middle cerebral artery occlusion

Year:  2020        PMID: 32538281      PMCID: PMC7983508          DOI: 10.1177/0271678X20925164

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  47 in total

Review 1.  Cardiovascular events associated with different combined oral contraceptives: a review of current data.

Authors:  P Hannaford
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Combined oral contraceptives and the risk of myocardial infarction.

Authors:  David Keeling
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

3.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

Review 4.  NLRP3 at the interface of metabolism and inflammation.

Authors:  Moritz Haneklaus; Luke A J O'Neill
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

5.  Stilbazulenyl nitrone, a second-generation azulenyl nitrone antioxidant, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat: neurobehavior, histopathology, and pharmacokinetics.

Authors:  James J Ley; Alexey Vigdorchik; Ludmila Belayev; Weizhao Zhao; Raul Busto; Larissa Khoutorova; David A Becker; Myron D Ginsberg
Journal:  J Pharmacol Exp Ther       Date:  2005-02-16       Impact factor: 4.030

6.  Quantitative assessment of the normal cerebral microvasculature by endothelial barrier antigen (EBA) immunohistochemistry: application to focal cerebral ischemia.

Authors:  B Lin; M D Ginsberg
Journal:  Brain Res       Date:  2000-05-26       Impact factor: 3.252

7.  Acinar zonation of cytosolic but not organelle-bound activities of phosphoenolpyruvate carboxykinase and aspartate aminotransferase in guinea-pig liver.

Authors:  L Agius; D Tosh
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

8.  Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells.

Authors:  Thomas J Abbruscato; Steve P Lopez; Karen S Mark; Brian T Hawkins; Thomas P Davis
Journal:  J Pharm Sci       Date:  2002-12       Impact factor: 3.534

9.  Acute effects of cigarette smoking on platelet-dependent thrombin generation.

Authors:  H Hioki; N Aoki; K Kawano; M Homori; Y Hasumura; T Yasumura; A Maki; H Yoshino; A Yanagisawa; K Ishikawa
Journal:  Eur Heart J       Date:  2001-01       Impact factor: 29.983

Review 10.  Energy Metabolism of the Brain, Including the Cooperation between Astrocytes and Neurons, Especially in the Context of Glycogen Metabolism.

Authors:  Anna Falkowska; Izabela Gutowska; Marta Goschorska; Przemysław Nowacki; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2015-10-29       Impact factor: 5.923

View more
  3 in total

1.  Chronic Nicotine Exposure Increases Hematoma Expansion following Collagenase-Induced Intracerebral Hemorrhage in Rats.

Authors:  Ashish K Rehni; Sunjoo Cho; Zhexuan Zhang; Weizhao Zhao; Ami P Raval; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Biomolecules       Date:  2022-04-21

Review 2.  Brain Energy Metabolism in Ischemic Stroke: Effects of Smoking and Diabetes.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Sabrina Rahman Archie; Ekram Ahmed Chowdhury; Thomas J Abbruscato
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

3.  Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.

Authors:  Mong-Lien Wang; Yi-Fan Hsu; Chih-Hsuan Liu; Ya-Ling Kuo; Yi-Chen Chen; Yi-Chen Yeh; Hsiang-Ling Ho; Yu-Chung Wu; Teh-Ying Chou; Cheng-Wen Wu
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.